SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Key facts: Aytu BioPharma Accepts $56M Buyout; Q1 Revenue Up 6.9%

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.

AYTU

Related stories